Search Results - "Perham, Matthew"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    ABBV-105, a selective and irreversible inhibitor of Bruton's tyrosine kinase, is efficacious in multiple preclinical models of inflammation by Goess, Christian, Harris, Christopher M., Murdock, Sara, McCarthy, Richard W., Sampson, Erik, Twomey, Rachel, Mathieu, Suzanne, Mario, Regina, Perham, Matthew, Goedken, Eric R., Long, Andrew J.

    Published in Modern rheumatology (04-05-2019)
    “…Objectives: Bruton's tyrosine kinase (BTK) is a non-receptor tyrosine kinase required for intracellular signaling downstream of multiple immunoreceptors. We…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4